Trial intelligence / Profile preview

BCG-CORONA trial in healthcare workers during the COVID-19 pandemic

NL-OMON49761Phase 3Active, not recruiting

Sponsor
University Medical Center Utrecht
Start
Mar 2020
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing BCG vaccine with Placebo (2 arms). Primary endpoint: Number of days of unplanned absenteeism for any reason. Started Mar 2020; status: active, not recruiting.

02

Drugs

bcg vaccine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NL-OMON49761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call